ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1444	National Cancer Institute	Html	en	Adult Acute Myeloid Leukemia Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of adult acute myeloid leukemia.	characteristic genetic abnormalities 0.39234 Adult Acute Myeloid 0.42781 acute myelogenous leukemia 0.488829 acute biphenotypic leukemia 0.454638 Acute myeloblastic leukemia 0.474183 acute erythroblastic leukemia 0.447971 monoblastic leukemia antigens 0.403407 transient leukemia 0.398296 Leukemia Group 0.421425 acute eosinophilic leukemia 0.464145 acute leukemias 0.416535 biphenotypic acute leukemia 0.461147 acute monocytic leukaemia 0.396733 chronic myeloid leukemia 0.484726 chronic myelomonocytic leukemia 0.40262 AML 0.598074 World Health Organization 0.418965 Health Organization Classification 0.417813 acute monocytic leukemia 0.541741 minimally differentiated AML 0.404409 acute erythroid leukemias. 0.391545 acute leukemia patients 0.46612 blast percentage 0.399782 myelodysplastic syndromes 0.404558 et al. 0.486443	lineage acute leukemia 0.472137 acute megakaryoblastic leukemia 0.570037 acute biphenotypic leukaemia 0.396849 internal tandem duplication 0.391126 Br J Haematol 0.407064 acute monoblastic leukemia 0.552455 adult megakaryoblastic leukemia 0.392499 acute myeloid leukemia 0.936356 acute myeloid leukaemia 0.463297 acute myelomonocytic leukemia 0.509496 genetic abnormalities 0.393333 acute megakaryocytic leukemia 0.467082 differential diagnosis 0.419864 cases 0.405688 Abstract 0.458712 pure erythroid leukemia 0.448165 cytochemical features 0.408002 acute erythroid leukemia 0.471063 bone marrow 0.469209 acute erythroid leukemias 0.400236 acute promyelocytic leukemia 0.615165 acute nonlymphocytic leukemia 0.489262 acute lymphoblastic leukemia 0.489649 acute leukemia 0.565771	CLICK HERE
1539	National Cancer Institute	Html	en	Adult Primary Liver Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of adult primary liver cancer.	Adult liver cancer 0.3229 bile duct cancer 0.289957 cancer spreads 0.268265 body 0.335412 healthy liver tissue 0.301199 PDQ cancer information 0.323551 clinical trial search 0.281007 clinical trials 0.55174 cancer information summary 0.30136 adult primary liver 0.896168 clinical trial 0.389615 liver disease 0.276306 detailed pictures 0.294233 healthy donated liver 0.285489 treatment clinical trial 0.264079 body radiation therapy 0.304178 NCI PDQ cancer 0.273742 malignant tumor cells 0.27026 Duct Cancer Treatment 0.289551 radiation therapy 0.397919 Childhood Liver Cancer 0.337182 entire liver 0.272876 general cancer information 0.265929 treatment 0.426881 liver injury 0.286661	hepatic portal vein 0.283724 Clinic Liver Cancer 0.322316 metastatic liver cancer 0.323102 nearby healthy tissue 0.265169 NCI-supported cancer 0.264234 cancer cells 0.36535 hepatic artery 0.317753 primary liver cancer 0.97153 Cancer Information Service 0.266321 specific cancer cells 0.265527 Liver Cancer Treatment 0.368965 patient 0.265351 treatment clinical trials 0.285012 National Cancer Institute 0.332241 stereotactic body radiation 0.30319 liver transplant 0.296023 new treatment 0.282659 external radiation therapy 0.294036 blood 0.29169 PDQ summary 0.268144 cancer clinical trials 0.30738 tumor 0.3047 cancer information summaries 0.264877 comprehensive cancer information 0.264661	CLICK HERE
1634	National Cancer Institute	Html	en	Hydrazine Sulfate (PDQ®)–Patient Version	Expert-reviewed information summary about the use of hydrazine sulfate as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.	randomized controlled trials 0.450078 treatment 0.522727 cancer treatment 0.475015 cancer prevention 0.44047 Complementary Therapies Editorial 0.452982 United States 0.440744 Drug Administration 0.454034 Cancer Information Specialist 0.44699 cancer cells 0.451523 Cancer Information Service 0.478296 hydrazine compounds 0.44033 PDQ cancer information 0.502287 Cancer Complementary 0.451114 body weight 0.443552 hydrazine sulfate treatment 0.519798 preclinical studies 0.453016 CAM therapies 0.439277 treatment clinical trials 0.44455 National Cancer Institute 0.557582 studies 0.47528 clinical trials 0.59962 colon cancer patients 0.451298 alternative medicine 0.474569 conventional treatment 0.441057	cancer information summary 0.479257 alternative cancer therapies 0.448575 Federal Trade Commission 0.442333 National Institutes 0.438958 clinical trial 0.445969 lung cancer patients 0.451382 CAM cancer research 0.443791 nutritional status 0.439129 breast cancer prevention 0.438548 advanced cancer 0.438703 patients 0.50459 cancer patients 0.480463 Cancer Care page 0.43981 health 0.440064 hydrazine sulfate 0.914395 PDQ summary 0.439248 NCI PDQ cancer 0.463099 cancer information database 0.449512 effects 0.440229 alternative therapies 0.459489 cancer information summaries 0.449727 Therapies Editorial Board 0.445847 randomized clinical trials 0.444095	CLICK HERE
1660	National Cancer Institute	Html	en	Liver (Hepatocellular) Cancer Screening (PDQ®)–Patient Version	Expert-reviewed information summary about tests used to detect or screen for liver (hepatocellular) cancer.	PDQ Screening 0.551346 hepatocellular) cancer: 0.719756 cancer treatment 0.490974 cancer screening methods 0.577774 United States 0.488028 ongoing clinical trials 0.569331 routine screening tests 0.542104 Abnormal screening results 0.526706 following PDQ summaries 0.569947 Cancer Information Service 0.537158 PDQ cancer information 0.763376 false-negative test result 0.487695 widely used tumor 0.492628 common cancer 0.497307 Prevention Editorial Board 0.554017 treatment clinical trials 0.497409 National Cancer Institute 0.639479 clinical trials 0.758209 early detection 0.490925 PDQ documents 0.509492 test result 0.528806 cancer information summary 0.632034 new treatment 0.500882 breast cancer prevention 0.517023	diagnostic tests 0.505464 test results 0.489974 Cancer screening trials 0.585626 tumor markers 0.491268 NCI website 0.503158 false-positive test result 0.487287 cancer patients 0.48575 Cancer Care page 0.521215 PDQ database 0.515283 latest published information 0.502276 specific tumor marker 0.485952 NCI’s PDQ 0.524006 risk factor 0.495527 PDQ summary 0.551372 liver biopsy 0.551147 cancer symptoms 0.506472 NCI PDQ cancer 0.600996 Chinese American men 0.489845 tests 0.559642 cancer information summaries 0.546479 comprehensive cancer information 0.546147 cancer 0.936669 liver cancer 0.793964	CLICK HERE
1874	National Cancer Institute	Html	es	Tratamiento de los tumores extragonadales de células germinativas (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de los tumores extragonadales de células germinativas.	germ-cell tumors 0.383819 metastatic germ 0.316138 germ-cell tumors with 0.328427 residual mass 0.330871 Nichols CR 0.459486 Greco FA 0.321626 initial salvage therapy 0.319174 largo plazo 0.317683 following systemic chemotherapy 0.321834 with germ-cell tumors 0.328027 malignant germ-cell tumors 0.322658 single-institution experience with 0.326215 unknown primary site 0.318402 germ cell tumours 0.337125 Extragonadal germ 0.317435 Cell Cancer Collaborative 0.335481 Hainsworth JD 0.322365 cell or non-germ 0.330347 Williams SD 0.32023 salvage treatment 0.337434 high-dose chemotherapy 0.334497 Instituto Nacional 0.329901 International Germ Cell 0.371979 Tumores mixtos 0.340879 Advanced poorly differentiated 0.316704	cell malignancy after 0.327663 primary mediastinal nonseminomatous 0.349396 unrecognized germ 0.316359 patients with 0.426473 Kramar A 0.320119 germ cell neoplasms 0.33799 disseminated germ 0.332449 Einhorn LH 0.38746 Germ Cell Consensus 0.341019 effective chemotherapy regimen 0.321136 Salvage chemotherapy 0.319709 germ cell 0.988418 PDQ Tratamiento 0.334355 extragonadal nonseminomatous germ 0.321388 Indiana University 0.317574 Clin Oncol 0.830939 as salvage treatment 0.323614 mediastinal germ-cell tumors 0.323089 mediastinal nonseminomatous germ 0.353563 postchemotherapy residual mass 0.322319 germ cell tumors 0.75596 Catalano PJ 0.324048 Oncology Group 0.318284 germ cell cancer 0.426267	CLICK HERE
3768	National Cancer Institute	Html	en	NCI Research Specialist Award (R50)	Award enables scientists to pursue stable research careers within an existing cancer research program, but not serve as independent investigators. Letter of Intent due: January 2, 2017 Application due: February 2, 2017	Research Specialist Award 0.988915 core-based scientists 0.581471 grant applications 0.550206 stable research career 0.730099 NCI-funded cancer research 0.716667 PM local time 0.654064 Funding Opportunity Announcements 0.676968 context 0.428705 FOA 0.51866 laboratory-based scientists 0.56909 sufficient autonomy 0.601601 grants 0.427207 cancer research program 0.718023 development 0.427246	data scientists 0.569495 researchers 0.4266 biomedical research enterprise. 0.720253 Intent 0.437384 R50 0.455052 opportunities 0.427151 exceptional scientists 0.586489 applicant organization 0.552188 Principal Investigators 0.571254 core facility managers 0.705581 NCI Research Specialist 0.740871 career continuity 0.565048 FOAs 0.534084 independent investigators. 0.567464	CLICK HERE
14597	National Cancer Institute	Html	en	Common Cancer Myths and Misconceptions	The latest science-based information concerning some common misconceptions about cancer. Learn the facts to worry less and make good health decisions.	cancer treatment 0.293552 multiple family members 0.287169 different surgical tools 0.292574 best studies 0.351264 wrong ideas 0.256786 individual cancer patient 0.352232 Cancer patients 0.292909 artificial sweeteners 0.340098 Cancer Vaccines 0.299159 bladder cancer 0.291637 good prevention 0.259057 Cancer Risk 0.329552 tobacco smoke 0.287568 environmental factors 0.290117 Risk Factors 0.292696 magnetic energy 0.286101 complementary therapies 0.281474 person 0.354916 cancers 0.347867 Five-year survival rates 0.302006 common cancer myths 0.360301 Metastatic Cancer 0.322576 Annual Report 0.258223 NCI fact sheet 0.996571 United States 0.312478	excess weight gain 0.296228 cancer cells 0.333742 5-year survival rate 0.300282 Helicobacter pylori 0.298521 personal hair dye 0.285054 natural result 0.291706 Hereditary Cancer Syndromes 0.328419 cell phones 0.296722 scientific evidence 0.293613 No. Researchers 0.257042 needless worry 0.25947 old theories 0.256313 transplant-related cancer 0.304436 NCI fact sheets 0.326267 Botanicals/Herbal Products section 0.288672 No. 0.263456 Breast Cancer 0.289863 medicine products—including vitamins 0.287253 latest science-based information 0.32382 power lines 0.324548 thyroid cancers 0.300398 Certain popular ideas 0.304234 cancer 0.824886 information 0.40326	CLICK HERE
15636	National Cancer Institute	Html	null	Step 6: Post-Award Administration	Information on numerous requirements that must be met in order to to be in compliance with NIH policy after receiving an award. This includes implementing monitoring systems and keeping financial and programmatic records.			CLICK HERE
16254	National Cancer Institute	Html	es	Genómica del cáncer	La investigación de fundamentos genéticos del cáncer ha mejorado nuestro entendimiento de la biología del cáncer y ha conducido a nuevos métodos de diagnosticar y tratar la enfermedad.	colores vibrantes 0.499759 programas de investigación 0.654055 posibles genes 0.505721 próxima generación 0.497158 prácticas de participación 0.488897 cambios genómicos que 0.533603 NCI al hacerlos 0.685799 gen braf 0.523508 cáncer y programas 0.967985 proteínas. el nci 0.703749 gen her2 0.525613 investigadores representaciones 0.514115 facilidad de acceso 0.490645 alta calidad 0.874691 línea germinal y exposiciones 0.549891	el instituto nacional 0.489007 cuáles tratamientos 0.520412 pequeño porcentaje 0.500295 Genoma Humano 0.547332 pacientes correctos 0.574878 tratamientos en investigación 0.520771 genes candidatos 0.501572 tratamientos correctos 0.52447 Estudios Clínicos del NCI 0.817174 determinada terapia 0.501736 rasgos genómicos y el 0.775836 mutaciones impulsoras 0.525134 la investigación aplicable 0.503499 datos estén 0.521046	CLICK HERE
16448	National Cancer Institute	Html	en	Identifying Novel Drug Combinations to Overcome Treatment Resistance	A review of current research identifying and testing drug combination approaches that have the potential to overcome or delay resistance to cancer treatment.	cancer treatment 0.25347 cancer cell lines—a 0.280999 healthy cells 0.296062 novel drug combinations 0.308632 lung cancer 0.280527 chemotherapy resistance 0.310051 cancer drug resistance 0.46496 Kettering Cancer Center 0.280587 effective drug pairs 0.26607 clinical trials 0.313646 epigenetic alterations 0.2886 original drug 0.25941 molecular alterations 0.297668 myeloid cells 0.309525 ovarian cancer 0.356692 cisplatin resistance 0.289204 patients 0.50622 immune checkpoint inhibitors 0.342594 single tumor 0.262236 Nature Reviews Cancer 0.299509 potential drug combinations 0.282064 tumor—contain molecular alterations 0.269672 combination treatment approach 0.285984 multidrug resistance section 0.355811 drug resistance 0.805264	cancer drugs 0.296242 treatment 0.450602 Cancer Research UK 0.305072 ABC transporter inhibitors 0.39367 chemotherapy drugs 0.281313 breast cancer tumors 0.293816 cancer cells 0.926321 cancer cell lines 0.386565 so-called intrinsic resistance 0.362006 epigenetic alteration 0.261391 Dana-Farber Cancer Institute 0.280545 Dr. Gottesman 0.323556 DNA methylation 0.280984 Cancer Research 0.350827 ABC transporters 0.47073 Hospital Cancer Center 0.277242 epigenetic codes—molecular modifications 0.267446 cancer researchers 0.266263 inactivating T cells 0.270905 drugs 0.323984 ovarian cancer cell 0.296997 drug combinations 0.458324 tumor microenvironment 0.309626 lung cancer cell 0.275824	CLICK HERE